United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-211_2b487fd0-f18e-c5c5-e063-6394a90aa1a8
- Product NDC
- 71610-211
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160218
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 CAPSULE in 1 BOTTLE, PLASTIC (71610-211-60) · 71610-211-60
- 120 CAPSULE in 1 BOTTLE, PLASTIC (71610-211-70) · 71610-211-70
- 180 CAPSULE in 1 BOTTLE, PLASTIC (71610-211-80) · 71610-211-80
- 270 CAPSULE in 1 BOTTLE, PLASTIC (71610-211-92) · 71610-211-92
- 360 CAPSULE in 1 BOTTLE, PLASTIC (71610-211-94) · 71610-211-94
- 540 CAPSULE in 1 BOTTLE, PLASTIC (71610-211-98) · 71610-211-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →